Private Market View

Carmot Therapeutics

Biotechnology

Last price · $/share
Implied valuation
Total raised
$310.0M
Last round
Later Stage VC (Series E)
May 2023
Team — not yet on record

No current team members for Carmot Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 5 rounds
  • ·Watchlist + deal alerts for Carmot Therapeutics
Create free account
No card required